#98: HVAD Is Off the Market - Now What?

June 30, 2021

Following the market removal of the HeartWare Ventricular Assist Device (HVAD) system, surgeons and industry representatives from the US and Europe discuss patient care implications, including new data from the Intermacs Database on survival benefits from a device exchange. The latest episode of the STS Webinar Series is presented in conjunction with the International Society for Heart and Lung Transplantation. Participants include: Jennifer A. Cowger, MD, MS, A. Pieter Kappetein, MD, PhD, Arman Kilic, MD, Robert L. Kormos, MD, FRCSC, Nahush A. Mokadam, MD, Francis D. Pagani, MD, PhD (moderator), Diyar Saeed, MD, PhD.